SOD2 and hypertensive disorder: In clinically hypertensive human subjects, although Sirt3 glutathionylation was not examined, SOD2 acetylation was significantly increased, suggesting that both Sirt3 deacetylase and SOD2 dismutase activity are inhibited in hypertension (Table 4; Dikalova et al., 2017).